Product Deployments Was the Most-widely Adopted Growth Strategy in the Health Information Exchange Market

According to the new market research report "Health Information Exchange Market by Set Up Type (Public, Private), Type (Pull, Push), Implementation Model (Federated, Hybrid), Application (Web Portal, Secure Messaging), Solution Type (Portal, Platform Centric), & End Users - Global Forecast to 2020", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, opportunities, key players, competitive landscape, and geographical markets.


The health information exchange market is expected to reach USD 1,545.0 Million by 2020 from USD 990.6 Million in 2015, at a CAGR of 9.3%. North America dominated the market in 2015, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period.
By application, the market is segmented into web portal development, workflow management, secure messaging, internal interfacing, and others (personal health records and chronic disease management). The web portal development segment accounted for the largest share of the health information exchange market in 2015. However, the internal interfacing segment is expected to grow at the highest CAGR in the forecast period, owing to the rising need of streamlining workflow and reducing healthcare costs by eliminating medication errors.

On the basis of end users, the market is segmented into providers, payers, and pharmacies. The providers segment accounted for the largest share of the global health information exchange market in 2015. On the basis of region, the market is categorized into North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
On the basis of region, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounted for the largest share of the health information exchange market in 2015, followed by Europe and Asia-Pacific. The large share of the North American health information exchange market can primarily be attributed to the federal mandates in the U.S., rising number of accountable care organizations (ACOs) as end users for HIE platforms in the U.S., Canada’s efforts to enhance healthcare delivery, and digital health measures in Canada. However, the Asia-Pacific region is projected to grow at the highest CAGR during the forecast period.
Health Information Exchange Market
Allscripts Healthcare Solutions, Inc. (U.S.), RelayHealth Corporation (U.S.), Infor, Inc. (U.S.), Cerner Corporation (U.S.), eClinicalWorks (U.S.), NextGen Healthcare Information Systems, LLC (U.S.), Optum, Inc. (U.S.), Covisint Corporation (U.S.), Epic Corporation Inc. (U.S.), and Orion Health (New Zealand) are some of the key players in the global health information exchange market.

Comments

Post a Comment

Popular posts from this blog

Key Players in the Pyrogen Testing Market Focus on Partnerships, Agreements, & Collaborations, Acquisitions, New Product launches, and Expansions

Image
The report  " Pyrogen Testing Market  by Product (Instruments, Services, Kits and Reagents), Application (Pharmaceutical & Biotechnology, Medical Devices, Other), & by Test (In Vitro, LAL, Gel Clot, Turbidimetric, Chromogenic, Rabbit) - Global Forecasts to 2021 " ,  report provides a detailed overview of the major drivers, restraints, opportunities, current market trends, and strategies impacting the global pyrogen testing market along with the estimates and forecasts of the revenue and market share analysis. Speak to Analyst @  https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=255266155 The global pyrogen testing market is valued at $462.38 million in 2014 and is expected to grow at a CAGR of 12.23%, to reach $823.14 million by 2019. Pyrogen testing is used to determine the bacterial toxins in products intended for medical or veterinary use. Rapidly growing pharmaceutical and biotechnology industries are a major growth driver for this market. Further
Read more

Non Invasive Prenatal Testing Market| Market Trends by Instruments, Consumables, Method, Application and End User

The major factors driving the growth of this market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, launch of new and advanced NIPT products, and increasing maternal age (associated with growth in the risk of chromosomal abnormalities in babies). Furthermore, untapped emerging markets are expected to offer potential growth opportunities to players operating in the NIPT market during the forecast period. The non-invasive prenatal testing (NIPT) market is expected to reach USD 2.88 billion by 2021 from USD 1.35 billion in 2016, at a CAGR of 16.4% from 2016 to 2021. The instruments segment is divided into ultrasound device, NGS systems, PCR instruments, microarrays, and other instruments. In 2016, the consumables segment accounted for the largest share of the market. The high growth in this segment is attributed to the repeated requirements of consumables as compared to instruments in NIPT. Based on application
Read more

Global Glycomics Market Players Pursue the Strategies of Product Launches, Agreements, Expansions, Acquisitions, and Collaborations

Image
The major players in this market include Agilent Technologies (U.S.), Bruker Corp. (U.S.), Danaher Corp. (U.S.), New England Biolabs (U.S.), Prozyme Inc. (U.S.), Shimadzu Corp. (Japan), Sigma-Aldrich Corp. (U.S.), Takara Bio (Japan), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S.). The glycomics market is dominated by a few major players, with the top five players accounting for a majority of the market share. The top four players for glycomics enzymes, kits, and reagents have a combined market share of about 75.2% and for glycomics instruments have a combined market share of about 76.0%. The global glycomics market is highly evolved, with multiple different product segments. An analysis of market developments between 2011 and 2014 revealed that new product launches was the most important growth strategy employed by market leaders in this period. This strategy was adopted by most players in this market, except New England Biolabs (U.S.) and Takara Bio, Inc. (Japan).
Read more